Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Drug Eluting Stents In The Critically Ischemic Lower Leg 2 (DESTINY 2)

This study has been completed.
Information provided by (Responsible Party):
Flanders Medical Research Program Identifier:
First received: September 22, 2011
Last updated: March 6, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)